SCHEMBL6960571

SCHEMBL6960571

Fc1ccc(C2CCC(N3C[CH]CC3)CC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.44
KDM4E B2RXH2 2/20 0.44
MEN1 O00255 2/20 0.44
ALDH1A1 P00352 2/20 0.44
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
HPGD P15428 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ESRRG P62508 1/20 0.39
ATM Q13315 1/20 0.36
LMNA P02545 1/20 0.36
SLC18A3 Q16572 2/20 0.36
ABCB1 P08183 1/20 0.36
HRH3 Q9Y5N1 3/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
HTR1A P08908 1/20 0.35
DRD2 P14416 1/20 0.35
DRD1 P21728 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL737934 0.76
SCHEMBL7305035 0.75 KMT2A (0.69) KMT2AKDM4EMEN1ALDH1A1CYP2D6
SCHEMBL18161913 0.74 KDM1A (0.48) ATMCYP3A4CYP2C9HTR1ADRD2
SCHEMBL1066184 0.74 KDM1A (0.48) ATMCYP3A4CYP2C9HTR1ADRD2
SCHEMBL7970183 0.73 TRPC3 (0.48) KMT2AKDM4EMEN1ALDH1A1CYP2D6
Hydrogen Sulfide SCHEMBL28219443 0.72 KDM1A (0.46) ATMCYP3A4CYP2C9HTR1ADRD2
Ammonia Solution, Strong SCHEMBL22408764 0.72 KDM1A (0.46) ATMCYP3A4CYP2C9HTR1ADRD2
Hydrochloric Acid SCHEMBL7965026 0.72 TRPC3 (0.47) KMT2AKDM4EMEN1ALDH1A1CYP2D6
Hydrochloric Acid SCHEMBL7965029 0.72 TRPC3 (0.47) KMT2AKDM4EMEN1ALDH1A1CYP2D6
SCHEMBL3682231 0.70 KDM1A (0.41) ALDH1A1SMN1; SMN2ATMHTR1ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0998285-A4 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2003-01-08 EP claimed
EP-0998285-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2000-05-10 EP claimed
WO-1998057641-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1998-12-23 WO claimed
EP-0998285-A4 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2003-01-08 EP disclosed
US-6255315-B1 BENIGN PROSTATIC HYPERPLASIA MERCK & CO., INC. 2001-07-03 US disclosed
EP-0998285-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2000-05-10 EP disclosed
WO-1998057641-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1998-12-23 WO disclosed